Advertisement

Medicinal Chemistry Research

, Volume 21, Issue 12, pp 4037–4042 | Cite as

Simultaneous determination of lisinopril and H2 antagonists in API, formulations and human serum by using two different HPLC systems

  • Safila NaveedEmail author
  • Najma Sultana
  • M. Saeed Arayne
Original Research

Abstract

An isocratic reversed phase high-performance liquid chromatographic method has been developed for the simultaneous determination of lisinopril and H2 antagonists (cimetidine, ranitidine, and famotidine) in bulk, dosage formulations, and human serum at 225 nm. Chromatographic separation was achieved using mobile phase, acetonitrile:water (70:25 v/v) adjusted to pH 3.0 via phosphoric acid 85% with flow rate of 1 ml/min at room temperature. Calibration curves were linear over range of 0.7–12.50 μg/ml for H2 antagonists and 2.5–100 μg/ml for lisinopril with a correlation coefficient ± 0.999. Limit of detection and limit of quantitation were in the ranges of 0.07–10.4 ng/ml. Intra- and inter-day precision and accuracy results were 98.0–102%.

Keywords

Lisinopril Cimetidine Ranitidine Famotidine HPLC 

References

  1. Betto P, Ciranni-Signoretti E, Di Fava R (1991) Determination of cimetidine and related impurities in pharmaceutical formulations by high-performance liquid chromatography. J Chromatogr 586:149–152PubMedCrossRefGoogle Scholar
  2. Carlucci G, Biordi L, Napolitano T, Bologna M (1988) Determination of famotidine in plasma, urine and gastric juice by high-performance liquid chromatography using disposable solid-phase extraction columns. J Pharm Biomed Anal 6:515PubMedCrossRefGoogle Scholar
  3. Cvitkovic L, Zupancickralj L, Marsel J (1991) Determination of famotidine in human plasma and urine by high-performance liquid chromatography. J Pharm Biomed Anal 9:207PubMedCrossRefGoogle Scholar
  4. Dowling TC, Frye RF (1999) Determination of famotidine in human plasma and urine by high-performance liquid chromatography. J Chromatogr B 732:239CrossRefGoogle Scholar
  5. El-Gindy A, Ashour A, Abdel-Fattah L, Shabana MM (2001) Spectrophotometric, septrofluorimetric and LC determination of lisinopril. J Pharm Biomed Anal 25:913–922PubMedCrossRefGoogle Scholar
  6. El-Yazbi FA, Abdine HH, Shaalan RA (1999) Spectrophotometric and spectrofluorometric methods for the assay of lisinopril in single and multicomponent pharmaceutical dosage forms. J Pharm Biomed Anal 19:819–827PubMedCrossRefGoogle Scholar
  7. Evans MB, Haywood PA, Johnson D, Martin-Smith M G Munro, Wahlich JC (1989) Chromatographic methods for determining the identity, strength and purity of ranitidine hydrochloride both in the drug substance and its dosage from-an exercise in method selection, development, definition and validation. J Pharm Biomed Anal 7:1–22PubMedCrossRefGoogle Scholar
  8. Goodman and Gilman’s (2001) In: Hardman JG, Limbird LE (eds) The pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York, p 1009Google Scholar
  9. Ho C, Huang HM, Hsu SY, Shaw CY, Chang BL (1999) Simultaneous high-performance liquid chromatographic analysis for famotidine, ranitidine HCl, cimetidine, and nizatidine in commercial products. Drug Develop Ind Pharm 25:379–385CrossRefGoogle Scholar
  10. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use, ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures. Text and Methodology Q2 (R 1), Complementary Guideline on Methodology dated 06 November 1996, incorporated in November 2005, LondonGoogle Scholar
  11. Iqbal T, Kinjo CS, Ngan GC, Dowling TC (2004) Validation of a simplified method for determination of cimetidine in human plasma and urine by liquid chromatography with ultraviolet detection. J Chromatogr B 799:337CrossRefGoogle Scholar
  12. Kunitani MG, Johnson DA, Upton RA, Riegelman S (1981) Convenient and sensitive high-performance liquid chromatography assay for cimetidine in plasma or urine. J Chromatogr 224:156PubMedCrossRefGoogle Scholar
  13. Munro JS, Walker TA (2001) Ranitidine hydrochloride: development of an isocratic stabilityindicating high-performance liquid chromatographic separation. J Chromatogr A 914:13–21PubMedCrossRefGoogle Scholar
  14. Paraskevas G, Atta-Politou J, Koupparis M (2002) Spectrophotometric determination of Lisinipril in tablets using 1-fluoro-2,4-dinitrobenzene. J Pharm Biomed Anal 29:819–872CrossRefGoogle Scholar
  15. Patchett AA, Harris E, Tristram EW, Wyratt MJ, Wu MP, Taub D, Peterson ER, Ikeler TJ, Tenbroeke J, Payne LG, Ondeyka DL, Thorsett ED, Greenlee WJ, Lohr NS, Hoffsommer RD, Joshua H, Ruyle WV, Rothrock JW, Aster SD, Maycock AL, Robinson FM, Hirschmann R, Sweet CS, Ulm EH, Gross DM, Vassal TC, Stone CA (1980) A new class of angiotensin-converting enzyme inhibitors. Nature 288:280–283PubMedCrossRefGoogle Scholar
  16. Prueksaritanont T, Sittichai N, Prueksaritanont S, Vongsaroj R (1989) Simultaneous determination of ranitidine and its metabolites in human plasma and urine by high-performance liquid chromatography. J Chromatogr 490:175PubMedCrossRefGoogle Scholar
  17. Strong HA, Spino M (1987) Highly sensitive determination of cimetidine and its metabolites in serum and urine by high-performance liquid chromatography. J Chromatogr Biomed Appl 422:301CrossRefGoogle Scholar
  18. Tsakalof A, Bairachtari K, Georgarakis M (2003) Development of a liquid chromatography-mass spectrometry method for monitoring the angiotensin-converting enzyme inhibitor lisinopril in serum. J Chromatogr B 783:425–432CrossRefGoogle Scholar
  19. United States Pharmacopeia (2007) National Formulary, Validation of Compendial Methods, vol 1225. Rockville, p 549Google Scholar
  20. Wong YC, Charles BG (1995) Determination of the angiotensin-converting enzyme inhibitor lisinopril in urine using solid-phase extraction and reversed phase high performance liquid chromatography. J Chromatogr B 673:306–310CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Faculty of PharmacyJinnah University for WomenKarachiPakistan
  2. 2.United BiotechnologiesKarachiPakistan

Personalised recommendations